INVO Bioscience, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
INVO Bioscience, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • INVO Bioscience, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.9M, a 7.89% increase year-over-year.
  • INVO Bioscience, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$5.24M, a 45.5% increase year-over-year.
  • INVO Bioscience, Inc. annual Operating Income (Loss) for 2023 was -$6.77M, a 36.3% increase from 2022.
  • INVO Bioscience, Inc. annual Operating Income (Loss) for 2022 was -$10.6M, a 104% decline from 2021.
  • INVO Bioscience, Inc. annual Operating Income (Loss) for 2021 was -$5.22M, a 5.41% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5.24M -$1.9M +$163K +7.89% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$5.41M -$946K +$1.36M +59% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$6.77M -$1.51M +$1.21M +44.5% Oct 1, 2023 Dec 31, 2023 10-K/A 2024-04-17
Q3 2023 -$7.98M -$886K +$1.64M +64.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 -$9.62M -$2.07M +$616K +23% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$10.2M -$2.31M +$395K +14.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$10.6M -$2.72M -$3.22M -640% Oct 1, 2022 Dec 31, 2022 10-K/A 2024-04-17
Q3 2022 -$7.4M -$2.53M -$252K -11.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$7.15M -$2.68M -$795K -42.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$6.36M -$2.7M -$1.14M -73.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$5.22M $504K +$2.29M Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$7.51M -$2.27M -$1.01M -79.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$6.5M -$1.89M -$824K -77.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$5.68M -$1.56M -$163K -11.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$5.51M -$1.79M -$1.05M -141% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$4.47M -$1.27M -$635K -100% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$3.83M -$1.06M -$997K -1515% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$2.84M -$1.4M -$1.05M -300% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$1.79M -$741K -$227K -44.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-30
Q3 2019 -$1.56M -$632K -$442K -233% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$1.12M -$65.8K +$1.72M +96.3% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$2.84M -$349K -$209K -149% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$2.63M -$513K -$316K -161% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$2.32M -$190K -$45.6K -31.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$2.27M -$1.79M -$1.66M -1252% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$614K -$140K +$26.4K +15.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$640K -$197K +$73.3K +27.1% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$714K -$144K +$63.1K +30.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$777K -$132K +$1.32M +90.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$2.1M -$167K +$14K +7.73% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$2.11M -$270K -$33.3K -14% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-29
Q3 2016 -$2.08M -$207K -$88.6K -74.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$1.99M -$1.45M -$1.34M -1252% Apr 1, 2016 Jun 30, 2016 10-Q 2017-09-05
Q1 2016 -$644K -$181K -$48.8K -37% Jan 1, 2016 Mar 31, 2016 10-Q 2017-09-05
Q4 2015 -$595K -$237K +$1.06M +81.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-20
Q3 2015 -$1.66M -$119K -$14.1K -13.5% Jul 1, 2015 Sep 30, 2015 10-Q 2017-09-05
Q2 2015 -$1.64M -$107K +$66.4K +38.2% Apr 1, 2015 Jun 30, 2015 10-Q 2017-09-05
Q1 2015 -$1.71M -$132K -$27.4K -26.2% Jan 1, 2015 Mar 31, 2015 10-Q 2017-09-05
Q4 2014 -$1.68M -$1.3M -$1.16M -830% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-17
Q3 2014 -$523K -$105K +$19.7K +15.8% Jul 1, 2014 Sep 30, 2014 10-K 2017-03-17
Q2 2014 -$542K -$174K -$23.9K -16% Apr 1, 2014 Jun 30, 2014 10-K 2017-03-17
Q1 2014 -$518K -$104K +$86.9K +45.4% Jan 1, 2014 Mar 31, 2014 10-K 2017-03-17
Q4 2013 -$605K -$140K -$24K -20.8% Oct 1, 2013 Dec 31, 2013 10-K 2017-03-17
Q3 2013 -$581K -$124K +$36K +22.4% Jul 1, 2013 Sep 30, 2013 10-K 2017-03-17
Q2 2013 -$617K -$150K +$10K +6.28% Apr 1, 2013 Jun 30, 2013 10-K 2017-03-17
Q1 2013 -$627K -$191K -$75K -64.4% Jan 1, 2013 Mar 31, 2013 10-K 2017-03-17
Q4 2012 -$552K -$116K Oct 1, 2012 Dec 31, 2012 10-K 2017-03-17
Q3 2012 -$160K +$12.2K +7.05% Jul 1, 2012 Sep 30, 2012 10-K 2017-03-17
Q2 2012 -$160K +$44.6K +21.8% Apr 1, 2012 Jun 30, 2012 10-K 2017-03-17
Q1 2012 -$116K Jan 1, 2012 Mar 31, 2012 10-K 2017-03-17
Q3 2011 -$172K +$192K +52.7% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-21
Q2 2011 -$205K +$105K +34% Apr 1, 2011 Jun 30, 2011 10-Q 2011-08-22
Q3 2010 -$365K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
Q2 2010 -$310K Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.